What side effects should I watch for at any step
Keywords: glucagon-like peptide 1 receptor agonists, semaglutide, salivary glands, xerostomia, cyclic AMP, beta-arrestins Abstract This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used for diabetes and obesity
17 Brain Changes Technological advances in neuroimaging techniques have allowed scientists to observe the brains of children diagnosed with ADHD and compare them to those of adolescents without the condition
They enhance myocardial glucose uptake, reduce inflammation and oxidative stress, and prevent apoptosis
In many cases, the health improvements seen with GLP-1 use (especially weight loss and blood sugar control) are not sustained after the medication is discontinued